Congenital diarrhea 7 with exudative enteropathy is a very rare inherited intestinal disease. It usually starts in the newborn period or early infancy. The baby has chronic watery diarrhea, loses protein through the gut, and may develop poor growth, low blood protein, swelling, and malnutrition. This condition is most strongly linked to biallelic disease-causing changes in the DGAT1 gene, so many doctors also call it DGAT1 deficiency or DIAR7. It is usually inherited in an autosomal recessive way, which means the child gets one changed copy of the gene from each parent.
Congenital diarrhea 7 with exudative enteropathy is a very rare inherited disease usually caused by biallelic DGAT1 gene variants. It is also called DGAT1 deficiency. In this disease, the small intestine cannot handle dietary fat normally. Because of that, the child may develop early watery diarrhea, vomiting, protein-losing enteropathy, low albumin, low immunoglobulins, poor weight gain, swelling, and malnutrition. It is an autosomal recessive condition, so the child usually receives one nonworking gene copy from each parent. The most important treatment is usually strict fat restriction with careful nutrition support, not a single “curative” medicine.
This disorder is best managed by a pediatric gastroenterologist, metabolic dietitian, and nutrition team. Many children improve when long-chain fat is reduced very strongly, and some need amino-acid or elemental formula, parenteral nutrition, essential fatty acid supplementation, vitamins, minerals, and treatment of complications. Because this is a rare disease, treatment plans are usually individualized according to stool output, growth, liver tests, albumin, fatty acid status, and feeding tolerance.
Another names
Other names used for this disorder include Diarrhea 7, DIAR7, DGAT1 deficiency, congenital chronic diarrhea with exudative enteropathy, and congenital chronic diarrhea with protein-losing enteropathy. These names point to the same basic problem: the intestine cannot handle fat normally, the gut lining becomes injured, and protein leaks into the bowel.
Types
Doctors do not always divide this disease into official fixed subtypes, but in practice it can be understood in simple clinical groups. These include classic neonatal-onset disease, where severe diarrhea starts very early; early-infantile disease, where symptoms appear in the first weeks or months; protein-losing enteropathy–dominant disease, where low albumin and swelling are very clear; malnutrition-dominant disease, where poor weight gain and vitamin problems are major features; delayed or milder presentation, where diarrhea appears later than usual; and mixed disease, where diarrhea, vomiting, edema, and growth failure happen together. These are practical clinical patterns, not a universally accepted formal classification.
Causes
For this rare disease, there is really one main root cause: harmful changes in both copies of the DGAT1 gene. To match your request for 20 causes in a medically honest way, the list below includes the main genetic causes plus important cause-related mechanisms and risk situations that lead to the disease or make it appear strongly.
- Homozygous DGAT1 mutation means the child inherits the same harmful DGAT1 change from both parents. This can remove or sharply reduce normal DGAT1 enzyme function.
- Compound heterozygous DGAT1 mutation means the child inherits two different harmful DGAT1 variants, one from each parent. This is also a common genetic pattern in reported cases.
- Loss-of-function variants are changes that stop the DGAT1 enzyme from working well or at all. This is the main disease mechanism in many patients.
- Nonsense mutations can create an early stop signal in the gene. This can produce a short, nonworking protein.
- Frameshift mutations can change the reading frame of the gene and lead to a damaged protein. Several reported disease variants work this way.
- Splice-site mutations can disturb how the gene message is cut and joined. This may lead to missing or abnormal protein pieces.
- Missense mutations can change one important amino acid in DGAT1 and lower enzyme activity. Some patients have this type of variant.
- Severely reduced triglyceride synthesis is a key downstream cause of symptoms. DGAT1 normally helps make triglycerides in intestinal cells.
- Defective intestinal fat absorption happens because the intestine cannot process dietary fat normally. This helps drive diarrhea and malnutrition.
- Lipotoxic injury to enterocytes may happen when fat-related molecules build up in the intestinal lining and harm the cells.
- Protein-losing enteropathy develops when the damaged intestine leaks protein into the bowel lumen. This causes low albumin and swelling.
- Possible bile acid handling problems may also contribute to diarrhea in some patients with DGAT1 deficiency.
- Autosomal recessive inheritance is the inheritance cause pattern. Both parents are often unaffected carriers.
- Carrier parents raise the chance that a child inherits two harmful DGAT1 copies. This explains family clustering in some cases.
- Consanguinity can increase the chance of recessive disorders in general, including this one, because related parents are more likely to carry the same rare variant.
- Family history of similar infant illness can point to the genetic cause, especially when siblings had early watery diarrhea or failure to thrive.
- Introduction of fat-containing feeds can bring out symptoms more strongly because DGAT1-deficient intestines struggle with dietary fat.
- Poor response to routine formulas may reflect the underlying DGAT1 cause, because many babies do not improve with standard feeding approaches alone.
- Severe nutrient loss from chronic diarrhea becomes part of the disease cycle and worsens the enteropathy. This does not start the gene defect, but it strongly drives the illness severity.
- Delayed genetic diagnosis can allow prolonged exposure to unsuitable feeding and ongoing intestinal damage. Again, this is not the original gene cause, but it is an important cause of worsening disease expression.
Symptoms
- Chronic watery diarrhea is the most important symptom. The stools are usually non-bloody and can be frequent and severe.
- Diarrhea starting very early in life is common. Many babies become sick in the first days, weeks, or months.
- Failure to thrive means the child does not gain weight and length as expected. This happens because nutrients are not absorbed well.
- Vomiting can happen with the diarrhea and feeding intolerance.
- Low blood albumin is common because protein leaks into the gut. This is a key clue.
- Edema or body swelling may appear when albumin becomes very low. The feet, face, or whole body can look puffy.
- Dehydration can happen because of large fluid loss in stool. This may become dangerous in infants.
- Malnutrition develops from poor absorption of fat, protein, and calories.
- Hypogammaglobulinemia means low blood antibodies in some patients, often related to protein loss.
- Repeated infections may occur in some children, partly because of low immunoglobulins and poor nutrition.
- Fat-soluble vitamin deficiency can develop, especially deficiencies of vitamins such as vitamin D.
- Poor bone health or rickets-like problems may appear when vitamin D and nutrition stay low for a long time.
- Hypertriglyceridemia has been reported in some cases, even though the main problem is intestinal fat handling.
- Digital clubbing has been described in some patients with chronic severe disease.
- Need for parenteral nutrition or albumin infusion is not just a treatment issue; it also reflects how severe the symptoms can become in early life.
Diagnostic tests
The diagnosis usually needs a step-by-step work-up. Doctors first confirm that the baby truly has severe chronic diarrhea and protein loss, then they exclude common causes, and finally they use genetic testing to confirm DGAT1-related disease.
- General physical exam checks weight, length, hydration, swelling, and overall nutrition. This gives the first big clinical picture.
- Growth chart assessment is very important because failure to thrive is common. Repeated weight and length measurements help show severity.
- Skin turgor check is a simple manual dehydration test. Poor skin recoil can suggest fluid loss.
- Capillary refill time is another bedside manual test. Slow refill can suggest dehydration or poor circulation.
- Pitting edema examination checks for swelling caused by low albumin. It supports protein-losing enteropathy.
- Abdominal examination and palpation look for distension, tenderness, bowel sounds, and other clues that may suggest a different disease.
- Stool inspection checks whether the stool is watery, fatty, bloody, or mucus-filled. This is a key first sorting step in congenital diarrhea work-up.
- Complete blood count (CBC) helps look for anemia, infection clues, and general nutritional impact.
- Serum albumin is one of the most important lab tests because low albumin strongly supports enteric protein loss.
- Total serum protein helps measure how much protein has been lost overall.
- Electrolyte panel checks sodium, potassium, chloride, and bicarbonate because chronic diarrhea can cause dangerous imbalance.
- Liver function and metabolic blood tests help look at overall organ stress and nutritional status.
- Immunoglobulin levels can show hypogammaglobulinemia in patients losing protein through the gut.
- Vitamin and micronutrient tests, especially fat-soluble vitamins, help measure malabsorption severity.
- Stool alpha-1 antitrypsin is a major test for protein-losing enteropathy. High stool levels support protein leakage from the intestine.
- Stool cultures and infection studies are done to rule out common infectious causes before diagnosing a genetic diarrheal disorder.
- Upper endoscopy and/or colonoscopy with biopsy may be used when doctors need tissue information or need to exclude other congenital enteropathies.
- Histopathology of intestinal biopsy can help separate DGAT1-related disease from other congenital diarrheal disorders, even though genetic testing is the key confirmation test.
- Electrocardiogram (ECG) is an electrodiagnostic test that may be useful when severe diarrhea causes major electrolyte problems, especially potassium abnormalities. It does not diagnose DGAT1 itself, but it helps assess complications.
- Molecular genetic testing for DGAT1 is the confirmatory test. This may be a targeted gene test, congenital diarrhea panel, or broader genomic sequencing. Finding biallelic pathogenic DGAT1 variants confirms the diagnosis.
Non-pharmacological treatments
1) Very-low-fat diet. This is the main treatment. It lowers the fat load reaching the intestine, so damaged fat handling causes less diarrhea and less protein loss. The purpose is to calm the bowel and improve growth. The mechanism is simple: less long-chain dietary fat means less toxic lipid buildup inside enterocytes and less leakage from the gut wall. Many reports describe major improvement after strict fat restriction.
2) Low-fat amino-acid or elemental formula. Some infants tolerate these formulas better than standard milk-based feeds. The purpose is to give protein and calories in a form that is easier to absorb while keeping fat very low. The mechanism is reduced digestive burden and reduced fat-triggered enterocyte stress. Recent reports describe quick improvement in diarrhea and growth with low-fat amino-acid formula plans.
3) Breast milk adjustment or replacement when needed. Breast milk is healthy in general, but its fat content may worsen symptoms in DGAT1 deficiency. The purpose is symptom control when breast milk is not tolerated. The mechanism is lowering long-chain triglyceride exposure. This decision should be made carefully with specialists because infants still need safe nutrition and growth monitoring.
4) Careful calorie planning. Children need enough energy even when fat is restricted. The purpose is to prevent failure to thrive. The mechanism is replacing lost calories with tolerated carbohydrate and protein sources and adjusting feeds often. A dietitian usually calculates this very closely because severe underfeeding can worsen weakness, low albumin, and delayed development.
5) Essential fatty acid replacement. A child on a very-low-fat diet can become deficient in omega-3 and omega-6 essential fats. The purpose is to prevent skin problems, poor growth, and biochemical deficiency. The mechanism is giving only the minimum required essential fats in a carefully tolerated form and amount.
6) Trial of selected medium-chain triglycerides when tolerated. Some patients may tolerate certain MCT preparations better than long-chain fats, but this is not universal. The purpose is to provide extra calories. The mechanism is that medium-chain fats are handled differently from long-chain fats. Some recent case reports noted tolerance to C8 MCT oil, but this must be tested carefully.
7) Parenteral nutrition during severe disease. When diarrhea is extreme or growth is failing, intravenous nutrition may be needed. The purpose is bowel rest, nutrition rescue, and recovery from protein loss. The mechanism is giving calories, amino acids, fluids, electrolytes, trace elements, and sometimes lipids directly into the bloodstream instead of through the gut.
8) Fluid replacement therapy. Frequent watery stools can quickly cause dehydration. The purpose is to restore circulating volume and organ perfusion. The mechanism is oral or intravenous replacement of water and electrolytes according to losses. This is especially important in infants because they dehydrate fast.
9) Electrolyte monitoring and correction. Diarrhea may disturb sodium, potassium, bicarbonate, magnesium, and other minerals. The purpose is to prevent weakness, arrhythmia, and acidosis. The mechanism is frequent blood testing and targeted replacement.
10) Albumin and protein status monitoring. Protein-losing enteropathy can make albumin fall very low. The purpose is to detect severe leakage and malnutrition early. The mechanism is serial albumin, total protein, edema checks, and stool alpha-1 antitrypsin when needed.
11) Growth tracking. Weight, length, head circumference, and development need close follow-up. The purpose is to see whether the nutrition plan is working. The mechanism is repeated measurement and feed adjustment.
12) Fat-soluble vitamin surveillance. Vitamins A, D, E, and K may become low when fat intake is restricted or fat absorption is poor. The purpose is to protect bone, vision, nerves, and clotting. The mechanism is lab monitoring and targeted supplementation.
13) Iron and anemia monitoring. Chronic illness and poor intake can lead to anemia. The purpose is to support oxygen delivery and growth. The mechanism is checking hemoglobin, iron studies, and replacing deficiency if present.
14) Immunoglobulin monitoring. Some children have low IgG because protein is lost through the intestine, not because the immune system is born abnormal. The purpose is to tell true immune deficiency from protein loss. The mechanism is checking IgG and watching infection history together.
15) Liver monitoring. Long illness and parenteral nutrition can affect the liver. The purpose is early detection of cholestasis or other liver injury. The mechanism is repeated liver enzymes, bilirubin, and nutrition review.
16) Stool loss assessment. Counting stool number, volume, and appearance helps guide feeding changes. The purpose is to know whether treatment is helping. The mechanism is direct measurement of symptoms against diet changes.
17) Infection prevention during central-line use. Children on parenteral nutrition may need a central venous line. The purpose is to prevent line infections and sepsis. The mechanism is clean handling, dressing care, and rapid response to fever.
18) Family genetic counseling. The purpose is to explain inheritance, recurrence risk, and testing for relatives. The mechanism is counseling plus molecular confirmation of the DGAT1 variants.
19) Individualized food introduction. Solid foods should be introduced slowly and chosen for very low fat content. The purpose is to expand the diet without causing relapse. The mechanism is adding one food at a time and watching stool pattern and growth.
20) Long-term specialist follow-up. This disease changes over time, and tolerance may improve or remain narrow. The purpose is safe long-term growth and complication control. The mechanism is repeated adjustment by experienced pediatric teams.
Drug treatments or medical products used supportively
1) Zinc sulfate. Zinc may be needed when chronic diarrhea causes deficiency. Its purpose is to support growth, epithelial repair, and enzyme function. The FDA label for zinc sulfate injection notes dosing must be individualized and that higher needs may occur in patients with excess stool loss. Side effects depend on route and dose.
2) Calcitriol. Calcitriol may be used when vitamin D deficiency is significant and active replacement is needed under specialist care. Its purpose is to improve calcium absorption and bone health. The mechanism is active vitamin D action in the gut and bone. The FDA label warns about hypercalcemia risk, so it must be monitored carefully.
3) Omegaven (fish oil triglycerides injectable emulsion). This is not a disease-specific cure, but it may be used in selected children receiving prolonged parenteral nutrition, especially when PN-associated cholestasis is a concern. Its purpose is to provide intravenous lipid calories in a monitored setting.
4) Ursodiol. Some children on long-term parenteral nutrition may develop cholestasis. Ursodiol is sometimes used supportively for bile flow problems, though not specifically approved for DGAT1 deficiency. The purpose is liver support in selected cases. Dosing is individualized by the treating physician.
5) Loperamide. This antidiarrheal may sometimes be considered in older patients for symptom relief, but it is not a standard core treatment for infants with DGAT1 deficiency and has important age-related precautions. The FDA label warns against use in children younger than 2 years and notes serious safety concerns.
6) Intravenous albumin. Albumin can be used in hospital when severe hypoalbuminemia with edema or circulatory problems occurs. Its purpose is temporary intravascular protein support, but it does not stop ongoing intestinal protein loss. It is a bridge, not a cure. Evidence for the disease problem itself comes from the protein-losing enteropathy literature.
7) Oral rehydration solution components. These are medical electrolyte products used to treat dehydration from diarrhea. Their purpose is fluid and salt replacement. The mechanism is sodium-glucose coupled absorption in the intestine, which helps water move back into the body.
8) Potassium replacement. This may be needed when stool losses are high. Its purpose is to prevent muscle weakness and heart rhythm problems. The exact dose depends on laboratory results and kidney function.
9) Magnesium replacement. Chronic diarrhea can lower magnesium. The purpose is support for muscle, nerve, and enzyme function. The dose depends on serum level and symptoms.
10) Sodium bicarbonate or citrate. These may be used when diarrhea causes metabolic acidosis. The purpose is acid-base correction. The mechanism is buffering excess acid loss or bicarbonate depletion.
11) Iron therapy. Iron is used when iron deficiency anemia is confirmed. Its purpose is to rebuild hemoglobin. The route and dose depend on tolerance and severity.
12) Vitamin K. This may be needed if fat-soluble vitamin deficiency develops. The purpose is to prevent abnormal bleeding.
13) Vitamin A. This may be used when deficiency appears. Its purpose is support for vision, immunity, and epithelial health.
14) Vitamin E. This may be needed in fat malabsorption states to protect nerves and cell membranes.
15) Standard parenteral amino acid solutions. These are used in parenteral nutrition to provide protein when the bowel cannot support growth.
16) Standard glucose/dextrose infusion solutions. These provide intravenous calories and help prevent catabolism during severe diarrhea or bowel rest.
17) Multivitamin preparations for parenteral nutrition. These are used to prevent multiple deficiencies during prolonged intravenous feeding.
18) Trace element mixtures for parenteral nutrition. These may include zinc and other essential minerals tailored to stool losses and growth needs.
19) Antibiotics when infection is proven. They are not routine treatment for DGAT1 deficiency itself, but are important for line infection, sepsis, or other confirmed infections.
20) Immunoglobulin replacement in selected severe secondary hypogammaglobulinemia. This is not routine. It may be considered only in special cases with significant infections and marked antibody loss, after specialist assessment.
Dietary molecular supplements
Essential fatty acid supplement, omega-3/6 blend, vitamin D, calcium, iron, zinc, magnesium, oral rehydration minerals, protein modular supplements, and selected MCT/C8 products may all be used only if deficiency or poor intake is present and the child tolerates them. In this disease, supplements are not chosen because they are fashionable; they are chosen because very-low-fat diets and chronic diarrhea can create real deficiencies. The exact product, dose, and route depend on labs, age, and stool response.
Immunity booster / regenerative / stem cell drugs
For this disease, there is no proven immunity-booster drug, regenerative drug, or stem cell drug that is standard evidence-based therapy. Current evidence supports diet therapy, nutrition rescue, correction of deficiencies, and complication management, not stem cell treatment. Using such terms for this condition would be misleading.
Surgeries or procedures
1) Central venous catheter placement may be needed for parenteral nutrition when enteral feeding fails. 2) Endoscopy with biopsy may help exclude other congenital enteropathies. 3) Genetic testing procedures confirm the diagnosis. 4) Imaging or liver assessment procedures may be needed if PN complications occur. 5) Catheter replacement or line procedures may be needed when central access fails or becomes infected. There is no usual curative bowel surgery for DGAT1 deficiency itself.
Prevention points
There is no way to prevent the gene mutation after conception, but complications can often be reduced by early diagnosis, fast fat restriction, careful hydration, close growth monitoring, essential fatty acid supplementation, vitamin monitoring, safe line care, regular liver checks, family education, and genetic counseling before future pregnancy. These steps help prevent malnutrition, severe dehydration, and delayed treatment.
When to see doctors urgently
Seek urgent medical care for very frequent watery stools, poor feeding, vomiting, less urine, dry mouth, unusual sleepiness, swelling, fever, blood in stool, fast weight loss, breathing trouble, or signs of line infection. In infants, dehydration and electrolyte problems can become dangerous quickly.
Foods to eat and avoid
Best choices are usually very-low-fat foods chosen with a dietitian: low-fat elemental formula when needed, lean protein in tolerated amounts, rice, potatoes, low-fat grains, fruits, vegetables, and other foods that do not trigger diarrhea. Avoid or limit high-fat milk, cream, butter, oils in large amounts, fried foods, fatty meats, many standard infant formulas, rich desserts, nut butters in large amounts, and other long-chain-fat-heavy foods unless the care team has said they are safe. Some children may tolerate small targeted essential-fat supplements or selected C8 MCT, but only under supervision.
FAQs
What is the other name? DGAT1 deficiency or congenital diarrhea 7.
Is it genetic? Yes, usually autosomal recessive.
What is the main symptom? Early watery diarrhea.
Why does swelling happen? Protein is lost through the intestine, so albumin drops.
Can it cause poor growth? Yes, failure to thrive is common.
What test confirms it? Genetic testing for DGAT1 variants.
Is stool alpha-1 antitrypsin useful? Yes, it can support protein-losing enteropathy.
What is the best treatment? A very-low-fat nutrition plan.
Can standard formula make it worse? It can in some infants because of fat content.
Do all children need parenteral nutrition? No, but some do during severe illness.
Can the child become vitamin deficient? Yes, especially fat-soluble vitamins and trace elements.
Is there a cure drug? No disease-specific FDA-approved cure drug is established.
Are stem cells standard treatment? No.
Can symptoms improve with age? Some children improve with careful diet management, but follow-up is still needed.
Should relatives get counseling? Yes, genetic counseling is important.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 31, 2025.
